Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis

Clinical trial NCT06644677 · COMPLETED

Trial details

NCT number: NCT06644677
Sponsor: Peking Union Medical College Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Cervical Cancers HPV Testing Nanopore Sequencing HPV Integration Site Detection Rapid Diagnosis

Start date: 2019-09-19
Primary completion: 2024-08-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.